**Question:** All of the following are true statements EXCEPT:

A. Sulfonamides are bacteriostatic antibiotics that inhibit the synthesis of nucleic acids in bacteria by competing with para-aminobenzoic acid (PABA) for the binding site of the enzyme dihydropteroate synthetase.
B. Macrolides act as competitive inhibitors of the binding of bacterial ribosomes to mRNA, blocking protein synthesis in bacteria.
C. Fluoroquinolones target bacterial DNA gyrase and topoisomerase IV, leading to DNA strand breakage and inhibition of bacterial replication.
D. Tetracyclines are bacteriostatic antibiotics that inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing the binding of aminoacyl-tRNA to the A-site of the ribosome.

**Correct Answer:** A. Sulfonamides are bacteriocidal antibiotics that inhibit the synthesis of nucleic acids in bacteria by competing with para-aminobenzoic acid (PABA) for the binding site of the enzyme dihydropteroate synthetase.

**Core Concept:**

Sulfonamides are a class of synthetic antimicrobial agents used to treat infections caused by bacteria that are susceptible to them. They work by inhibiting the synthesis of folic acid, which is essential for the growth and multiplication of bacteria. Sulfonamides achieve this by competing with para-aminobenzoic acid (PABA) for binding to the enzyme dihydropteroate synthetase, ultimately preventing the formation of dihydrofolic acid and thymidylate, which are crucial components of bacterial DNA and RNA synthesis.

**Why the Correct Answer is Right:**

Sulfonamides are bacteriocidal, meaning they kill bacteria directly by inhibiting their essential processes. In contrast, the other options are either bacteriostatic or involve indirect effects on bacterial growth and multiplication.

**Why Other Options are Incorrect:**

A. Bacteriostatic antibiotics, such as those mentioned in options B-D, inhibit bacterial growth but do not directly kill bacteria. They do not interfere with bacterial DNA or RNA synthesis like sulfonamides do.

B. Macrolides inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing the binding of aminoacyl-tRNA to the A-site of the ribosome, thus preventing peptide bond formation.

C. Fluoroquinolones act as inhibitors of bacterial DNA gyrase and topoisomerase IV, enzymes involved in the negative supercoiling of DNA during replication and transcription. This prevents the unwinding of DNA and prevents the synthesis of bacterial DNA.

D. Tetracyclines bind to the 30S ribosomal subunit, preventing the binding of aminoacyl-tRNA to the A-site of the ribosome, thereby inhibiting peptide bond formation and ultimately blocking protein synthesis in bacteria.

**Clinical Pearls:**

1. Bacteriostatic antibiotics are typically used in combination with bactericidal antibiotics to enhance treatment outcomes and reduce the development of antibiotic resistance.
2. Understanding the mode of action of different antibiotic